COMPANY

Odyssey Therapeutics (2)

Keywords: small molecule

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $214.03M (Form D filed Dec 4, 2025). SEC Form D 0001104659-25-118426 (Dec 4, 2025)
Evidence (1 event)
- Dec 4, 2025 · SEC Form D 0001104659-25-118426
  Name of Issuer: Odyssey Therapeutics, Inc.; CIK: 1882782; Address: Boston, MA; Submission type: D; Filing date: 2025-12-04; Industry Group: Biotechnology; Date of First Sale: 2025-06-16; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 214025200; Total Amount Sold: 214025200; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

May 8, 2026 Raise IPO: $304M (total, as published), announced May 8, 2026. Source: company release on GlobeNewswire. source ↗

Raised: $304.0M. Last 2 years.

May 8, 2026 IPO: $304M (total, as published), announced May 8, 2026. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2025-12-04 Raise Private raise (SEC Form D): $214.0M sold; issuer “Odyssey Therapeutics, Inc.”. Verified from the SEC filing. SEC filing ↗
InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗